Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP645531.RAv-_ROeoT6OF1IDEekIAz6hVUiK7l1rupOLn8NHVZ1CQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP645531.RAv-_ROeoT6OF1IDEekIAz6hVUiK7l1rupOLn8NHVZ1CQ130_assertion type Assertion NP645531.RAv-_ROeoT6OF1IDEekIAz6hVUiK7l1rupOLn8NHVZ1CQ130_head.
- NP645531.RAv-_ROeoT6OF1IDEekIAz6hVUiK7l1rupOLn8NHVZ1CQ130_assertion description "[GEP100 was expressed in 70% of primary breast ductal carcinomas, and was preferentially co-expressed with EGFR in the malignant cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645531.RAv-_ROeoT6OF1IDEekIAz6hVUiK7l1rupOLn8NHVZ1CQ130_provenance.
- NP645531.RAv-_ROeoT6OF1IDEekIAz6hVUiK7l1rupOLn8NHVZ1CQ130_assertion evidence source_evidence_literature NP645531.RAv-_ROeoT6OF1IDEekIAz6hVUiK7l1rupOLn8NHVZ1CQ130_provenance.
- NP645531.RAv-_ROeoT6OF1IDEekIAz6hVUiK7l1rupOLn8NHVZ1CQ130_assertion SIO_000772 18084281 NP645531.RAv-_ROeoT6OF1IDEekIAz6hVUiK7l1rupOLn8NHVZ1CQ130_provenance.
- NP645531.RAv-_ROeoT6OF1IDEekIAz6hVUiK7l1rupOLn8NHVZ1CQ130_assertion wasDerivedFrom befree-2016 NP645531.RAv-_ROeoT6OF1IDEekIAz6hVUiK7l1rupOLn8NHVZ1CQ130_provenance.
- NP645531.RAv-_ROeoT6OF1IDEekIAz6hVUiK7l1rupOLn8NHVZ1CQ130_assertion wasGeneratedBy ECO_0000203 NP645531.RAv-_ROeoT6OF1IDEekIAz6hVUiK7l1rupOLn8NHVZ1CQ130_provenance.